American Century Companies’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.7M | Sell |
322,427
-6,230
| -2% | -$1.36M | 0.03% | 633 |
|
|
2026
Q1 | $62.1M | Buy |
328,657
+37,298
| +13% | +$6.52M | 0.03% | 653 |
|
|
2025
Q4 | $49.5M | Buy |
291,359
+74,928
| +35% | +$11.5M | 0.02% | 738 |
|
|
2025
Q3 | $28.5M | Sell |
216,431
-36,599
| -14% | -$4.39M | 0.01% | 961 |
|
|
2025
Q2 | $26.9M | Buy |
253,030
+64,968
| +35% | +$7.06M | 0.01% | 945 |
|
|
2025
Q1 | $23.3M | Buy |
188,062
+27,650
| +17% | +$3.61M | 0.01% | 976 |
|
|
2024
Q4 | $19.8M | Buy |
160,412
+57,406
| +56% | +$6.77M | 0.01% | 1054 |
|
|
2024
Q3 | $11.5M | Buy |
103,006
+10,433
| +11% | +$1.14M | 0.01% | 1254 |
|
|
2024
Q2 | $9.88M | Sell |
92,573
-24,845
| -21% | -$2.73M | 0.01% | 1252 |
|
|
2024
Q1 | $14.1M | Buy |
117,418
+42,106
| +56% | +$5.16M | 0.01% | 1063 |
|
|
2023
Q4 | $9.26M | Sell |
75,312
-2,652
| -3% | -$331K | 0.01% | 1180 |
|
|
2023
Q3 | $10.1M | Buy |
77,964
+11,949
| +18% | +$1.59M | 0.01% | 1065 |
|
|
2023
Q2 | $8.18M | Sell |
66,015
-19,480
| -23% | -$2.62M | 0.01% | 1138 |
|
|
2023
Q1 | $12.5M | Buy |
85,495
+46,571
| +120% | +$6.89M | 0.01% | 933 |
|
|
2022
Q4 | $6.2M | Buy |
38,924
+12,482
| +47% | +$1.83M | 0.01% | 1140 |
|
|
2022
Q3 | $3.52M | Buy |
26,442
+12,650
| +92% | +$1.92M | ﹤0.01% | 1244 |
|
|
2022
Q2 | $2.15M | Sell |
13,792
-115,864
| -89% | -$17.8M | ﹤0.01% | 1395 |
|
|
2022
Q1 | $20.2M | Buy |
129,656
+674
| +0.5% | +$97.8K | 0.01% | 692 |
|
|
2021
Q4 | $16.4M | Buy |
128,982
+56,291
| +77% | +$7.4M | 0.01% | 745 |
|
|
2021
Q3 | $9.47M | Buy |
72,691
+530
| +0.7% | +$80.1K | 0.01% | 858 |
|
|
2021
Q2 | $12.8M | Buy |
72,161
+67,821
| +1,563% | +$11.7M | 0.01% | 766 |
|
|
2021
Q1 | $713K | Sell |
4,340
-448,636
| -99% | -$73.8M | ﹤0.01% | 1588 |
|
|
2020
Q4 | $74.8M | Buy |
452,976
+125,652
| +38% | +$18.7M | 0.06% | 315 |
|
|
2020
Q3 | $46.7M | Buy |
327,324
+96,778
| +42% | +$12M | 0.04% | 364 |
|
|
2020
Q2 | $25.4M | Sell |
230,546
-8,711
| -4% | -$963K | 0.02% | 461 |
|
|
2020
Q1 | $23.9M | Buy |
239,257
+157,105
| +191% | +$20.3M | 0.03% | 429 |
|
|
2019
Q4 | $12.3M | Sell |
82,152
-116,199
| -59% | -$15.8M | 0.01% | 633 |
|
|
2019
Q3 | $25.4M | Buy |
198,351
+78,019
| +65% | +$10.5M | 0.03% | 448 |
|
|
2019
Q2 | $17.2M | Sell |
120,332
-12,409
| -9% | -$1.67M | 0.02% | 534 |
|
|
2019
Q1 | $19M | Buy |
132,741
+19,768
| +17% | +$2.58M | 0.02% | 501 |
|
|
2018
Q4 | $14M | Sell |
112,973
-392,609
| -78% | -$58.2M | 0.02% | 539 |
|
|
2018
Q3 | $85M | Buy |
505,582
+90,521
| +22% | +$15.6M | 0.08% | 275 |
|
|
2018
Q2 | $71.5M | Buy |
415,061
+73,239
| +21% | +$12M | 0.07% | 306 |
|
|
2018
Q1 | $51.6M | Sell |
341,822
-156,157
| -31% | -$22.9M | 0.05% | 354 |
|
|
2017
Q4 | $67.1M | Sell |
497,979
-133,785
| -21% | -$18.6M | 0.07% | 319 |
|
|
2017
Q3 | $92.4M | Buy |
631,764
+81,864
| +15% | +$12.4M | 0.09% | 274 |
|
|
2017
Q2 | $85.5M | Buy |
549,900
+314,094
| +133% | +$48M | 0.09% | 280 |
|
|
2017
Q1 | $34.2M | Buy |
235,806
+220,624
| +1,453% | +$28.7M | 0.04% | 430 |
|
|
2016
Q4 | $1.66M | Sell |
15,182
-230
| -1% | -$25.6K | ﹤0.01% | 1068 |
|
|
2016
Q3 | $1.87M | Buy |
15,412
+1,122
| +8% | +$151K | ﹤0.01% | 1065 |
|
|
2016
Q2 | $2.02M | Sell |
14,290
-104,664
| -88% | -$15.4M | ﹤0.01% | 1027 |
|
|
2016
Q1 | $15.5M | Sell |
118,954
-82,364
| -41% | -$10.3M | 0.02% | 563 |
|
|
2015
Q4 | $28.3M | Sell |
201,318
-103,796
| -34% | -$14.4M | 0.03% | 461 |
|
|
2015
Q3 | $40.5M | Sell |
305,114
-60,043
| -16% | -$10.3M | 0.05% | 402 |
|
|
2015
Q2 | $64.3M | Buy |
365,157
+4,973
| +1% | +$893K | 0.07% | 341 |
|
|
2015
Q1 | $62.2M | Sell |
360,184
-76,785
| -18% | -$13.2M | 0.07% | 353 |
|
|
2014
Q4 | $71.5M | Buy |
436,969
+430,078
| +6,241% | +$71.4M | 0.08% | 320 |
|
|
2014
Q3 | $1.11M | Hold |
6,891
| – | – | ﹤0.01% | 1163 |
|
|
2014
Q2 | $1.01M | Sell |
6,891
-380
| -5% | -$52.7K | ﹤0.01% | 1214 |
|
|
2014
Q1 | $1.01M | Hold |
7,271
| – | – | ﹤0.01% | 1225 |
|
|
2013
Q4 | $920K | Buy |
7,271
+210
| +3% | +$21.7K | ﹤0.01% | 1261 |
|
|
2013
Q3 | $649K | Sell |
7,061
-164,791
| -96% | -$13.3M | ﹤0.01% | 1307 |
|
|
2013
Q2 | $11.8M | Buy |
+171,852
| New | +$10.5M | 0.02% | 628 |
|
Other funds holding JAZZ
VPM
VCM
American Century Companies's JAZZ Position: Q2 2026 in Review
American Century Companies reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.9% in Q2 2026, selling an estimated $1.36M and leaving 322,427 shares worth $77.7M. The position accounts for 0.03% of the portfolio, ranked #633.
American Century Companies first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $92.4M in Q3 2017. 564 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- American Century Companies held 322,427 shares of Jazz Pharmaceuticals worth $77.7M as of Q2 2026.
- American Century Companies sold 6,230 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.36M.
- Jazz Pharmaceuticals made up 0.03% of American Century Companies's portfolio in Q2 2026, its #633 holding.
- American Century Companies first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- American Century Companies's Jazz Pharmaceuticals position peaked at $92.4M in Q3 2017.
- 564 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.